Speaker illustration

Professor Apostolos Tsapas

Aristotle University of Thessaloniki, Thessaloniki (Greece)

Prof Apostolos Tsapas graduated from Aristotle University Thessaloniki. Following a fellowship at Oxford Centre for Diabetes Endocrinology and Metabolism, he studied for an MSc in Evidence-based healthcare at the University of Oxford. His research focuses on knowledge synthesis (systematic reviews and meta-analyses) and clinical decision-making in medicine and diabetes. He has been involved in the development of the joined ADA/EASD position statements on the management of hyperglycaemia in type 2 diabetes since 2012. He is the author of more than 100 peer-reviewed publications, many of them in top-ranking medical journals. Prof Tsapas is currently Professor of Medicine and Diabetes, Head of the Second Medical Department and founding Lead Investigator of the Clinical Research and Evidence-Based Medicine Unit at Aristotle University of Thessaloniki, and senior research fellow at Harris Manchester College, University of Oxford, UK.

Take-home messages: glucose-lowering medication after myocardial infarction in hospital and after discharge.

Event: ESC Congress 2022

Topic: Risk Factors and Prevention

Session: What the cardiologist must know: glucose-lowering medication after myocardial infarction in hospital and after discharge


Meta-analysis for omega-3 supplementation and cardiovascular disease

Event: ESC Congress 2017

Topic: Primary cardiovascular prevention: interventions and outcomes

Session: Prevention - Diet and obesity


Rethinking the appraisal and approval of drugs for type 2 diabetes.

Event: ESC Congress 2017

Topic: Drug therapy

Session: Treatment of type 2 diabetes - Important new aspects for the cardiologist


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb